Company
About Us
Our Story
Biomerix Corporation is a privately-held medical technology company focused on developing and commercializing innovative, cost-effective products based on its proprietary platform technology, the Biomerix BiomaterialTM.
Biomerix approaches its biomaterials technology and product development with a strong focus on innovation and patient care. The Company's commitment to meeting evolving clinical needs has led to the development of a device pipeline across a range of areas: soft tissue repair, neurovascular embolization, spine annular repair, cardiovascular repair and women's health.
Founded in October of 2001, Biomerix focused on developing a new class of biomaterial designed to support and enhance the tissue healing process. By 2004, the Company achieved a significant medical technology breakthrough and created the Biomerix Biomaterial, a revolutionary biointegrative synthetic tissue scaffold. The novel chemical formulation and physical structure of the Biomerix Biomaterial platform technology can be harnessed across a myriad of medical applications.
The Biomaterial's patented chemistry and structure constitutes a biocompatible, biostable scaffold, providing a suitable biological environment for the delivery of growth factors, stem cells, cytokines and therapeutic drugs. The Company has established partnerships to collaborate with leading academic researchers and top regenerative medicine companies across the world to maximize the potential of its Biomerix Biomaterial platform technology.